Levonorgestrel 1.5 MG Oral Tablet — RxCUI 483325
RxNorm drug concept · Semantic clinical drug
RxCUI 483325
Semantic clinical drug · SCD
● Current RxNorm concept 58 FDA products
65 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI483325
Official nameLevonorgestrel 1.5 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped58
Package NDCs mapped65
Reported Medicaid activity (SDUD)97,017 prescriptions · 41 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Levonorgestrel: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- They both contain levonorgestrel, but they work very differently. The IUS (like Mirena, Liletta, Kyleena, or Skyla) is a small device a provider places inside your uterus that slow...
- What's the difference between the IUS and the emergency contraceptive pill — are they the same thing?
- The sooner the better — you should take it within 72 hours (3 days) of unprotected sex. It becomes less effective the longer you wait, so don't delay. If you vomit within 2 hours o...
- How quickly do I need to take the emergency contraceptive tablet after sex?
🕸️ Concept Web — How Levonorgestrel 1.5 MG Oral Tablet Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Levonorgestrel 1.5 MG Oral Tablet
RxCUI 483325 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Levonorgestrel
6373IN
-
Levonorgestrel
-
Brand names 25
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
After banger
2644389BN -
Aftera
1598653BN -
Afterpill
1545298BN -
AfterPlan
2047723BN -
Curae
2631019BN -
E-Con
2261388BN -
EContra
1600597BN -
Fem Choice
2590818BN - +17 more in this family
-
After banger
-
Dose forms 56
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Levonorgestrel Oral Tablet
372591SCDF -
Levonorgestrel Oral Product
1163477SCDG -
Levonorgestrel Pill
1163478SCDG -
Levonorgestrel Oral Tablet [After banger]
2644393SBDF -
Levonorgestrel Oral Tablet [Aftera]
1598655SBDF -
Levonorgestrel Oral Tablet [Afterpill]
1545300SBDF -
Levonorgestrel Oral Tablet [AfterPlan]
2047725SBDF -
Levonorgestrel Oral Tablet [Curae]
2631023SBDF - +48 more in this family
-
Levonorgestrel Oral Tablet
-
Clinical & branded drugs 51
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Levonorgestrel 1.5 MG
483324SCDC -
Levonorgestrel 1.5 MG Oral Tablet [After banger]
2644394SBD -
Levonorgestrel 1.5 MG Oral Tablet [Aftera]
1598658SBD -
Levonorgestrel 1.5 MG Oral Tablet [Afterpill]
1545303SBD -
Levonorgestrel 1.5 MG Oral Tablet [AfterPlan]
2047728SBD -
Levonorgestrel 1.5 MG Oral Tablet [Curae]
2631024SBD -
Levonorgestrel 1.5 MG Oral Tablet [E-Con]
2261393SBD -
Levonorgestrel 1.5 MG Oral Tablet [EContra]
1600602SBD - +43 more in this family
-
Levonorgestrel 1.5 MG
Showing up to 8 concepts per family — 25 of 133 stored related concepts drawn.
The stored snapshot retains a bounded subset of a very large related-concept list; counts reflect what is stored.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Levonorgestrel 1.5 MG
SCDC · 483324 -
Levonorgestrel Oral Tablet
SCDF · 372591 -
Levonorgestrel Oral Product
SCDG · 1163477 -
Levonorgestrel Pill
SCDG · 1163478
Brand-Name Concepts
-
Levonorgestrel 1.5 MG Oral Tablet [After banger]
SBD · 2644394 -
Levonorgestrel 1.5 MG Oral Tablet [Aftera]
SBD · 1598658 -
Levonorgestrel 1.5 MG Oral Tablet [Afterpill]
SBD · 1545303 -
Levonorgestrel 1.5 MG Oral Tablet [AfterPlan]
SBD · 2047728 -
Levonorgestrel 1.5 MG Oral Tablet [E-Con]
SBD · 2261393 -
Levonorgestrel 1.5 MG Oral Tablet [EContra]
SBD · 1600602 -
Levonorgestrel 1.5 MG Oral Tablet [Fem Choice]
SBD · 2590823 -
Levonorgestrel 1.5 MG Oral Tablet [Her Style]
SBD · 1855519 -
Levonorgestrel 1.5 MG Oral Tablet [Ithappenz]
SBD · 2632742 -
Levonorgestrel 1.5 MG Oral Tablet [Julie]
SBD · 2606549
📦 FDA Products & Package NDCs
58 products · 65 package NDCs
65 package NDCs map to RxCUI 483325 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 71713-0098-11 | 1 BLISTER PACK in 1 CARTON (71713-098-11) / 1 TABLET in 1 B... | Levonorgestrel | Thirty Madison Inc. | 2025-01-02 |
| 72288-0324-28 | 1 BLISTER PACK in 1 CARTON (72288-324-28) / 1 TABLET in 1 B... | AMAZON BASIC CARE LEVONORGESTREL | Amazon.com Services LLC | 2024-05-15 |
| 72657-0108-12 | 1 BLISTER PACK in 1 CARTON (72657-108-12) / 1 TABLET in 1 B... | SheWise | GLENMARK THERAPEUTICS INC., USA | 2022-07-29 |
| 72657-0123-11 | 1 BLISTER PACK in 1 CARTON (72657-123-11) / 1 TABLET in 1 B... | Levonorgestrel | GLENMARK THERAPEUTICS INC., USA | 2023-02-09 |
| 73436-2859-01 | 1 BLISTER PACK in 1 CARTON (73436-2859-1) / 1 TABLET in 1 B... | Morning After Pill | Cadence Health Inc | 2023-10-01 |
| 73436-8292-01 | 1 BLISTER PACK in 1 BOX, UNIT-DOSE (73436-8292-1) / 1 TABLE... | Morning After Pill | Cadence Health Inc | 2025-04-15 |
| 73581-0217-01 | 1 BLISTER PACK in 1 CARTON (73581-217-01) / 1 TABLET in 1 B... | Levonorgestrel | YYBA Corp | 2026-03-01 |
| 79929-0016-01 | 1 BLISTER PACK in 1 BOX, UNIT-DOSE (79929-016-01) / 1 TABLE... | Levonorgestrel | Naari Pte Limited | 2023-02-16 |
| 80584-0103-01 | 1 BLISTER PACK in 1 CARTON (80584-103-01) / 1 TABLET in 1 B... | Restart | Winx Health Inc. | 2025-12-19 |
| 82791-0002-01 | 1 BLISTER PACK in 1 CARTON (82791-002-01) / 1 TABLET in 1 B... | Julie Morning After Pill | Julie Products Inc. | 2025-10-10 |
| 82791-0003-01 | 1 BLISTER PACK in 1 CARTON (82791-003-01) / 1 TABLET in 1 B... | Julie Morning After Pill | Julie Products Inc. | 2025-11-20 |
| 82791-0335-01 | 1 BLISTER PACK in 1 BOX, UNIT-DOSE (82791-335-01) / 1 TABLE... | Julie | Julie Products Inc | 2025-02-20 |
| 82791-0532-01 | 1 BLISTER PACK in 1 CARTON (82791-532-01) / 1 TABLET in 1 B... | Julie | Julie Products Inc. | 2022-10-28 |
| 82791-0538-01 | 1 BLISTER PACK in 1 CARTON (82791-538-01) / 1 TABLET in 1 B... | Julie | Julie Products Inc. | 2022-07-15 |
| 85506-0100-10 | 1 BLISTER PACK in 1 CARTON (85506-100-10) / 1 TABLET in 1 B... | PostDay One-Step | Home Health Brands, LLC | 2025-04-28 |
Observed labelers:
Aurohealth LLC (8) ·
Foundation Consumer Healthcare LLC (6) ·
Rapha Pharmaceuticals, Inc. (6) ·
Julie Products Inc. (4) ·
Camber Consumer Care Inc (3) ·
Ohm Laboratories Inc. (3)
· +28 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.